|
3 Companies |
|
2 Products |
|
2 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
22 News |
|
- | Trial completion date, Trial primary completion date: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Mar 7, 2023
P=N/A, N=240, Completed, Sponsor: H
Trial completion date: May 2018 --> Jan 2023 | Trial primary completion date: May 2018 --> Jan 2023
- | Trial completion date, Trial primary completion date: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Feb 11, 2019
P=N/A, N=200, Completed, Sponsor: H
Trial completion date: May 2018 --> Jan 2023 | Trial primary completion date: May 2018 --> Jan 2023 Trial completion date: Nov 2017 --> May 2018 | Trial primary completion date: Nov 2017 --> May 2018
- | Enrollment change, Trial completion date, Trial primary completion date: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Oct 23, 2018
P=N/A, N=200, Completed, Sponsor: H
Trial completion date: Nov 2017 --> May 2018 | Trial primary completion date: Nov 2017 --> May 2018 N=104 --> 200 | Trial completion date: Feb 2017 --> Nov 2017 | Trial primary completion date: Feb 2017 --> Nov 2017
- | prednisolone / Generic mfg.
Trial completion, Trial completion date, Trial initiation date: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma (clinicaltrials.gov) - Aug 23, 2018
P2/3, N=30, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
N=104 --> 200 | Trial completion date: Feb 2017 --> Nov 2017 | Trial primary completion date: Feb 2017 --> Nov 2017 Not yet recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Initiation date: May 2017 --> Dec 2016
- | Phase classification, Enrollment change: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=7, Completed, Sponsor: University of Pittsburgh
Not yet recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 | Initiation date: May 2017 --> Dec 2016 Phase classification: P1/2 --> P=N/A | N=15 --> 7
- | Trial completion: Protocol TARC-ABPA (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=29, Completed, Sponsor: Nantes University Hospital
Phase classification: P1/2 --> P=N/A | N=15 --> 7 Active, not recruiting --> Completed
- | Trial completion: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=104, Completed, Sponsor: H
Active, not recruiting --> Completed Recruiting --> Completed
- | prednisolone / Generic mfg.
New P2/3 trial: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma (clinicaltrials.gov) - Apr 27, 2017
P2/3, N=30, Not yet recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- Trial primary completion date: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Jan 10, 2017
P=N/A, N=104, Recruiting, Sponsor: H
Recruiting --> Completed Trial primary completion date: Sep 2016 --> Feb 2017
- || voriconazole / Generic mfg.
Trial completion: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Jan 4, 2017
P2/3, N=50, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: Sep 2016 --> Feb 2017 Active, not recruiting --> Completed
- | itraconazole / Generic mfg.
Trial completion, Enrollment change, Monotherapy: Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Jan 4, 2017
P2/3, N=100, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=50 --> 100
- New trial: Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=105, Recruiting, Sponsor: Ga
- Trial completion, Enrollment change, Trial primary completion date: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA (clinicaltrials.gov) - Feb 16, 2016
P=N/A, N=79, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed | N=50 --> 100 Recruiting --> Completed | N=300 --> 79 | Trial primary completion date: Dec 2012 --> Dec 2010
- Trial completion, Trial primary completion date: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Jan 16, 2016
P1/2, N=15, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | N=300 --> 79 | Trial primary completion date: Dec 2012 --> Dec 2010 Recruiting --> Completed | Trial primary completion date: Sep 2012 --> Sep 2013
- | voriconazole / Generic mfg.
Enrollment closed, Trial initiation date, Trial primary completion date: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Oct 22, 2015
P2/3, N=50, Active, not recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting --> Completed | Trial primary completion date: Sep 2012 --> Sep 2013 Recruiting --> Active, not recruiting | Initiation date: Jun 2012 --> Jun 2013 | Trial primary completion date: Jun 2015 --> Apr 2016
- itraconazole / Generic mfg.
Enrollment closed, Trial initiation date, Trial primary completion date, Monotherapy: Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Oct 22, 2015
P2/3, N=50, Active, not recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting --> Active, not recruiting | Initiation date: Jun 2012 --> Jun 2013 | Trial primary completion date: Jun 2015 --> Apr 2016 Recruiting --> Active, not recruiting | Initiation date: Jan 2011 --> Apr 2011 | Trial primary completion date: Jun 2015 --> Mar 2013
- Trial completion: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Aug 11, 2015
P2/3, N=21, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting --> Active, not recruiting | Initiation date: Jan 2011 --> Apr 2011 | Trial primary completion date: Jun 2015 --> Mar 2013 Recruiting --> Completed
- Enrollment closed: Protocol TARC-ABPA (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=30, Active, not recruiting, Sponsor: Nantes University Hospital
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial primary completion date: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Dec 30, 2014
P2/3, N=20, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting --> Active, not recruiting Trial primary completion date: May 2014 --> Jun 2015
- | voriconazole / Generic mfg.
Trial primary completion date: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Dec 30, 2014
P2/3, N=50, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: May 2014 --> Jun 2015 Trial primary completion date: Jun 2014 --> Jun 2015
- itraconazole / Generic mfg.
Trial primary completion date, Monotherapy: Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Dec 30, 2014
P2/3, N=50, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: Jun 2014 --> Jun 2015 Trial primary completion date: Jun 2013 --> Jun 2015
- Trial primary completion date: Protocol TARC-ABPA (clinicaltrials.gov) - Dec 25, 2014
P=N/A, N=30, Recruiting, Sponsor: Nantes University Hospital
Trial primary completion date: Jun 2013 --> Jun 2015 Trial primary completion date: May 2017 --> Nov 2017
- Trial primary completion date: Protocol TARC-ABPA (clinicaltrials.gov) - Oct 22, 2014
P=N/A, N=30, Recruiting, Sponsor: Nantes University Hospital
Trial primary completion date: May 2017 --> Nov 2017 Trial primary completion date: Nov 2016 --> May 2017
- New P2/3 trial: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - May 16, 2013
P2/3, N=20, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- Clinical: Protocol TARC-ABPA (clinicaltrials.gov) - Oct 17, 2012
P=N/A, N=30, Recruiting, Sponsor: Nantes University Hospital
- ||| voriconazole / Generic mfg.
New P2/3 trial: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Jun 14, 2012
P2/3, N=50, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- Clinical: Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients (clinicaltrials.gov) - Apr 3, 2012
P=N/A, N=40, Completed, Sponsor: Rambam Health Care Campus